Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Rimonabant

Obese Patients With or Without Comorbidities (RIO-North America)

Sanofi · Phase 3 · Completed · Enrollment 3045

NCT00029861

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Registry arm not namedn/rn/rn/rn/r

Not shown

  • Registry arm not named: endpoint not reported